| 1 |
29564133 |
10.1186/s40364-018-0126-y |
2022 |
Suitability of Yin Yang 1 transcript and protein levels for biomarker studies in B cell non-Hodgkin lymphoma. |
YY1 |
| 2 |
34039950 |
10.1038/s41408-021-00493-5 |
2022 |
Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing. |
YY1 |
| 3 |
35163649 |
10.3390/ijms23031728 |
2022 |
Transcriptional Regulation of Yin-Yang 1 Expression through the Hypoxia Inducible Factor-1 in Pediatric Acute Lymphoblastic Leukemia. |
YY1 |
| 4 |
32713953 |
10.24875/BMHIM.19000187 |
2021 |
Yin-Yang-1 decreases Fas-induced apoptosis in acute lymphoblastic leukemia under hypoxic conditions: its implications in immune evasion. |
YY1 |
| 5 |
32899428 |
10.3390/ijms21176446 |
2021 |
Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets. |
YY1 |
| 6 |
33179084 |
10.3892/mmr.2020.11666 |
2021 |
Effects and mechanism of microRNA‑218 against lung cancer. |
YY1 |
| 7 |
33410342 |
10.1080/10428194.2020.1869960 |
2021 |
KLF4 inhibition by Kenpaullone induces cytotoxicity and chemo sensitization in B-NHL cell lines via YY1 independent. |
YY1 |
| 8 |
33504766 |
10.1038/s41419-021-03425-0 |
2021 |
The DNA-helicase HELLS drives ALK<sup>-</sup> ALCL proliferation by the transcriptional control of a cytokinesis-related program. |
YY1 |
| 9 |
33544468 |
10.1515/hsz-2020-0276 |
2021 |
PCAT1 induced by transcription factor YY1 promotes cholangiocarcinoma proliferation, migration and invasion by sponging miR-216a-3p to up-regulate oncogene BCL3. |
YY1 |
| 10 |
33900899 |
10.1080/08880018.2020.1871139 |
2021 |
Expression of YY1 in pro-B and T phenotypes correlation with poor survival in pediatric acute lymphoblastic leukemia. |
YY1 |
| 11 |
26622779 |
10.3892/ol.2015.3498 |
2020 |
Role of annexin A6 in cancer. |
YY1 |
| 12 |
26893685 |
10.3892/ol.2015.4031 |
2020 |
Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt's lymphoma: A computational study. |
YY1 |
| 13 |
30277117 |
10.1080/10428194.2018.1516286 |
2020 |
Cytotoxic effect caspase activation dependent of a genetically engineered fusion protein with a CD154 peptide mimetic (OmpC-CD154<sub>p</sub>) on B-NHL cell lines is mediated by the inhibition of bcl-6 and YY1 through MAPK p38 activation. |
YY1 |
| 14 |
31040909 |
10.18632/oncotarget.26745 |
2020 |
Regulation of Krüppel-Like Factor 4 (KLF4) expression through the transcription factor Yin-Yang 1 (YY1) in non-Hodgkin B-cell lymphoma. |
YY1 |
| 15 |
32236631 |
10.3892/or.2020.7563 |
2020 |
17‑AAG synergizes with Belinostat to exhibit a negative effect on the proliferation and invasion of MDA‑MB‑231 breast cancer cells. |
YY1 |
| 16 |
33194748 |
10.3389/fonc.2020.588893 |
2020 |
MicroRNA-7 Regulates Migration and Chemoresistance in Non-Hodgkin Lymphoma Cells Through Regulation of KLF4 and YY1. |
YY1 |
| 17 |
29383875 |
10.1111/jcmm.13503 |
2019 |
Multiple roles of Ring 1 and YY1 binding protein in physiology and disease. |
YY1 |
| 18 |
29616858 |
10.1080/10428194.2018.1448083 |
2019 |
Role of Yin Yang-1 (YY1) in the transcription regulation of the multi-drug resistance (<i>MDR1</i>) gene. |
YY1 |
| 19 |
30098214 |
10.1111/imm.12990 |
2019 |
YY1 binds to the E3' enhancer and inhibits the expression of the immunoglobulin κ gene via epigenetic modifications. |
YY1 |
| 20 |
28724437 |
10.1186/s12943-017-0692-x |
2018 |
The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia. |
YY1 |
| 21 |
29695404 |
10.21873/cgp.20080 |
2018 |
Establishment and Characteristics of a Novel Mantle Cell Lymphoma-derived Cell Line and a Bendamustine-resistant Subline. |
YY1 |
| 22 |
28488543 |
10.1177/1010428317706210 |
2017 |
The transcription factor FOXA1 induces epithelial ovarian cancer tumorigenesis and progression. |
YY1 |
| 23 |
25791160 |
10.5301/jbm.5000134 |
2016 |
Identification of biomarkers for the prognosis of pancreatic ductal adenocarcinoma with miRNA microarray data. |
YY1 |
| 24 |
27225481 |
10.1186/s13046-016-0359-2 |
2016 |
Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication. |
YY1 |
| 25 |
25193702 |
10.1016/j.bbrc.2014.08.131 |
2015 |
Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance. |
YY1 |
| 26 |
24121673 |
10.1038/ncomms3598 |
2014 |
Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1. |
YY1 |
| 27 |
24481661 |
10.1007/s13277-014-1659-9 |
2014 |
Gene set enrichment analysis of the NF-κB/Snail/YY1/RKIP circuitry in multiple myeloma. |
YY1 |
| 28 |
23757039 |
10.1136/jclinpath-2013-201461 |
2013 |
PLK1 and YY1 interaction in follicular lymphoma is associated with unfavourable outcome. |
YY1 |
| 29 |
23766940 |
10.4103/2153-3539.109856 |
2013 |
A statistical framework for analyzing hypothesized interactions between cells imaged using multispectral microscopy and multiple immunohistochemical markers. |
YY1 |
| 30 |
22248058 |
10.1615/critrevoncog.v16.i3-4.80 |
2012 |
Yin Yang 1 in human cancer. |
YY1 |
| 31 |
22248059 |
10.1615/critrevoncog.v16.i3-4.90 |
2012 |
Overexpression of Yin Yang 1 in the pathogenesis of human hematopoietic malignancies. |
YY1 |
| 32 |
22267549 |
10.1158/1535-7163.MCT-11-0635 |
2012 |
Galiximab signals B-NHL cells and inhibits the activities of NF-κB-induced YY1- and snail-resistant factors: mechanism of sensitization to apoptosis by chemoimmunotherapeutic drugs. |
YY1 |
| 33 |
21109702 |
10.1136/jcp.2010.078188 |
2011 |
YY1 expression predicts favourable outcome in follicular lymphoma. |
YY1 |
| 34 |
21133714 |
10.3109/10428194.2010.531408 |
2011 |
A potential mechanism of rituximab-induced inhibition of tumor growth through its sensitization to tumor necrosis factor-related apoptosis-inducing ligand-expressing host cytotoxic cells. |
YY1 |
| 35 |
21228036 |
10.3324/haematol.2010.028605 |
2011 |
Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy. |
YY1 |
| 36 |
21282644 |
10.1073/pnas.1019537108 |
2011 |
Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program. |
YY1 |
| 37 |
21411522 |
10.1128/JVI.02659-10 |
2011 |
Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycle. |
YY1 |
| 38 |
20081364 |
10.4161/cc.9.3.10554 |
2010 |
Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression. |
YY1 |
| 39 |
20425315 |
10.1007/s11899-006-0001-z |
2010 |
What signals are generated by anti-CD20 antibody therapy? |
YY1 |
| 40 |
19188155 |
10.1158/1078-0432.CCR-08-1685 |
2009 |
In vivo model of follicular lymphoma resistant to rituximab. |
YY1 |
| 41 |
19513562 |
10.3892/ijo_00000323 |
2009 |
Combination treatment of malignant B cells using the anti-CD20 antibody rituximab and the anti-malarial artesunate. |
YY1 |
| 42 |
19861448 |
10.1158/1078-0432.CCR-09-1234 |
2009 |
Rituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functions. |
YY1 |
| 43 |
17973241 |
10.1002/path.2258 |
2008 |
The CD30 gene promoter microsatellite binds transcription factor Yin Yang 1 (YY1) and shows genetic instability in anaplastic large cell lymphoma. |
YY1 |
| 44 |
17255358 |
10.1182/blood-2006-09-046391 |
2007 |
Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling. |
YY1 |
| 45 |
17287852 |
10.1038/sj.leu.2404583 |
2007 |
Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer. |
YY1 |
| 46 |
17530016 |
10.1038/sj.onc.1210365 |
2007 |
Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions. |
YY1 |
| 47 |
17641042 |
10.4049/jimmunol.179.3.1760 |
2007 |
OX40 gene expression is up-regulated by chromatin remodeling in its promoter region containing Sp1/Sp3, YY1, and NF-kappa B binding sites. |
YY1 |
| 48 |
16103877 |
10.1038/sj.onc.1208954 |
2006 |
Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis. |
YY1 |
| 49 |
16147992 |
10.1074/mcp.M500112-MCP200 |
2006 |
Analysis of BCL6-interacting proteins by tandem mass spectrometry. |
YY1 |
| 50 |
16081784 |
10.4049/jimmunol.175.4.2174 |
2005 |
Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively. |
YY1 |
| 51 |
14707079 |
10.4049/jimmunol.172.2.1054 |
2004 |
NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells. |
YY1 |
| 52 |
14982841 |
10.1016/S0002-9440(10)63175-6 |
2004 |
Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines. |
YY1 |
| 53 |
12393438 |
10.1182/blood-2002-04-1207 |
2003 |
The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic differentiation. |
YY1 |
| 54 |
12954229 |
10.1016/s0042-6822(03)00379-9 |
2003 |
Triple basepair changes within and adjacent to the conserved YY1 motif upstream of the U3 enhancer repeats of SL3-3 murine leukemia virus cause a small but significant shortening of latency of T-lymphoma induction. |
YY1 |
| 55 |
10680598 |
10.1016/s0304-3835(99)00321-3 |
2000 |
Analysis of highly frequent allelic loss region on distal chromosome 12 in murine radiation-induced lymphomas. |
YY1 |
| 56 |
10858540 |
10.1016/s0167-4781(00)00098-1 |
2000 |
Early steps in termination of the immortalization state in Burkitt lymphoma: induction of genes involved in signal transduction, transcription, and trafficking by the ganglioside IV(3)NeuAc-nLcOse(4)Cer. |
YY1 |
| 57 |
8756632 |
10.1128/MCB.16.9.4744 |
1996 |
The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element. |
YY1 |
Datasets
Models
